Apabetalone, a drug that reduces MACE in CKD patients
|
18
|
Resverlogix Corp.
|
Jun 05, 2020 05:03PM
|
Resverlogix is hopefully applying for governmental fund for MACE in Covid-19
|
16
|
Resverlogix Corp.
|
May 10, 2020 04:16PM
|
Resverlax
|
15
|
Resverlogix Corp.
|
Jun 12, 2017 06:27PM
|
Exceptionally good news
|
14
|
Resverlogix Corp.
|
Nov 18, 2019 10:21AM
|
Re: Odd
|
13
|
Resverlogix Corp.
|
Dec 08, 2020 04:31AM
|
Important article published yesterday (January 4), RVX208 relevant
|
13
|
Resverlogix Corp.
|
Jan 05, 2019 07:34AM
|
Re: Bear
|
12
|
Resverlogix Corp.
|
Jan 28, 2016 12:02PM
|
Comments re AHA presentation
|
12
|
Resverlogix Corp.
|
Nov 16, 2019 06:32PM
|
Re: Constellation Pharma
|
12
|
Resverlogix Corp.
|
Jun 30, 2020 08:29AM
|
Re: Quote from a January 19, 2021 review
|
12
|
Resverlogix Corp.
|
Jan 21, 2021 08:31AM
|
Some calculations on efficacy
|
12
|
Resverlogix Corp.
|
May 31, 2018 05:45PM
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
12
|
Resverlogix Corp.
|
Nov 29, 2021 05:40PM
|
Quote from a January 19, 2021 review
|
12
|
Resverlogix Corp.
|
Jan 20, 2021 03:36PM
|
Did you know...?
|
10
|
Resverlogix Corp.
|
Jul 05, 2017 04:33PM
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
10
|
Resverlogix Corp.
|
Oct 14, 2020 03:00PM
|
Re: VOLUME
|
10
|
Resverlogix Corp.
|
Jun 30, 2021 06:26AM
|
RVX AGM and Zenith AGM, my thoughts
|
10
|
Resverlogix Corp.
|
Sep 12, 2016 05:04PM
|
Their finest hour
|
10
|
Resverlogix Corp.
|
Sep 24, 2019 01:31PM
|
ABBV-744 is BD2 specific - worth a read
|
10
|
Resverlogix Corp.
|
Feb 02, 2022 03:26PM
|
Re: p-values : are correct
|
10
|
Resverlogix Corp.
|
Feb 24, 2017 09:27AM
|